173 related articles for article (PubMed ID: 25392324)
1. Increased anti-KIR4.1 antibodies in multiple sclerosis: could it be a marker of disease relapse?
Brill L; Goldberg L; Karni A; Petrou P; Abramsky O; Ovadia H; Ben-Hur T; Karussis D; Vaknin-Dembinsky A
Mult Scler; 2015 Apr; 21(5):572-9. PubMed ID: 25392324
[TBL] [Abstract][Full Text] [Related]
2. Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis.
Nerrant E; Salsac C; Charif M; Ayrignac X; Carra-Dalliere C; Castelnovo G; Goulabchand R; Tisseyre J; Raoul C; Eliaou JF; Labauge P; Vincent T
Mult Scler; 2014 Nov; 20(13):1699-703. PubMed ID: 24756568
[TBL] [Abstract][Full Text] [Related]
3. Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease.
Kraus V; Srivastava R; Kalluri SR; Seidel U; Schuelke M; Schimmel M; Rostasy K; Leiz S; Hosie S; Grummel V; Hemmer B
Neurology; 2014 Feb; 82(6):470-3. PubMed ID: 24415573
[TBL] [Abstract][Full Text] [Related]
4. Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4.
Kim W; Lee JE; Li XF; Kim SH; Han BG; Lee BI; Kim JK; Choi K; Kim HJ
Mult Scler; 2012 May; 18(5):578-86. PubMed ID: 21965418
[TBL] [Abstract][Full Text] [Related]
5. Enhanced accumulation of Kir4.1 protein, but not mRNA, in a murine model of cuprizone-induced demyelination.
Nakajima M; Kawamura T; Tokui R; Furuta K; Sugino M; Nakanishi M; Okuyama S; Furukawa Y
Brain Res; 2013 Nov; 1537():340-9. PubMed ID: 24070676
[TBL] [Abstract][Full Text] [Related]
6. Humoral Responses to Diverse Autoimmune Disease-Associated Antigens in Multiple Sclerosis.
Malyavantham K; Weinstock-Guttman B; Suresh L; Zivadinov R; Shanahan T; Badgett D; Ramanathan M
PLoS One; 2015; 10(6):e0129503. PubMed ID: 26065913
[TBL] [Abstract][Full Text] [Related]
7. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients.
Fazio R; Malosio ML; Lampasona V; De Feo D; Privitera D; Marnetto F; Centonze D; Ghezzi A; Comi G; Furlan R; Martino G
Mult Scler; 2009 Oct; 15(10):1153-63. PubMed ID: 19667009
[TBL] [Abstract][Full Text] [Related]
8. Low reliability of anti-KIR4.1
Marino M; Frisullo G; Di Sante G; Samengo DM; Provenzano C; Mirabella M; Pani G; Ria F; Bartoccioni E
Mult Scler; 2018 Jun; 24(7):910-918. PubMed ID: 28548026
[TBL] [Abstract][Full Text] [Related]
9. Detection of potassium channel KIR4.1 antibodies in Multiple Sclerosis patients.
Marnetto F; Valentino P; Caldano M; Bertolotto A
J Immunol Methods; 2017 Jun; 445():53-58. PubMed ID: 28300540
[TBL] [Abstract][Full Text] [Related]
10. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
[TBL] [Abstract][Full Text] [Related]
11. Anti-KIR4.1 Antibodies in Chinese Patients with Central Nervous System Inflammatory Demyelinating Disorders.
Zhong R; Liang J; Tao A; Wu L; Yang X; Xu H; Huang Q; Zhuang S; Long Y; Gao C
Neuroimmunomodulation; 2016; 23(5-6):295-300. PubMed ID: 28391264
[TBL] [Abstract][Full Text] [Related]
12. Serum antibodies to 25 myelin oligodendrocyte glycoprotein epitopes in multiple sclerosis and neuromyelitis optica: clinical value for diagnosis and disease activity.
Xu Y; Zhang Y; Liu CY; Peng B; Wang JM; Zhang XJ; Li HF; Cui LY
Chin Med J (Engl); 2012 Sep; 125(18):3207-10. PubMed ID: 22964310
[TBL] [Abstract][Full Text] [Related]
13. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay.
Hayakawa S; Mori M; Okuta A; Kamegawa A; Fujiyoshi Y; Yoshiyama Y; Mitsuoka K; Ishibashi K; Sasaki S; Hattori T; Kuwabara S
J Neuroimmunol; 2008 May; 196(1-2):181-7. PubMed ID: 18462810
[TBL] [Abstract][Full Text] [Related]
14. Combined screening for serum anti-nuclear and anti-aquaporin-4 antibodies improves diagnostic accuracy for distinguishing neuromyelitis optica from multiple sclerosis.
Wu L; Huang D; Yang Y; Wu W
Eur Neurol; 2014; 72(1-2):103-8. PubMed ID: 24993096
[TBL] [Abstract][Full Text] [Related]
15. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
Paul F; Jarius S; Aktas O; Bluthner M; Bauer O; Appelhans H; Franciotta D; Bergamaschi R; Littleton E; Palace J; Seelig HP; Hohlfeld R; Vincent A; Zipp F
PLoS Med; 2007 Apr; 4(4):e133. PubMed ID: 17439296
[TBL] [Abstract][Full Text] [Related]
16. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse.
Wang HH; Dai YQ; Qiu W; Lu ZQ; Peng FH; Wang YG; Bao J; Li Y; Hu XQ
J Clin Neurosci; 2011 Oct; 18(10):1313-7. PubMed ID: 21795048
[TBL] [Abstract][Full Text] [Related]
18. Plasma sCD28, sCTLA-4 levels in neuromyelitis optica and multiple sclerosis during relapse.
Wang H; Wang K; Zhong X; Dai Y; Wu A; Li Y; Hu X
J Neuroimmunol; 2012 Feb; 243(1-2):52-5. PubMed ID: 22177277
[TBL] [Abstract][Full Text] [Related]
19. Multiple Sclerosis and Antibodies against KIR4.1.
Pröbstel AK; Kuhle J; Lecourt AC; Vock I; Sanderson NS; Kappos L; Derfuss T
N Engl J Med; 2016 Apr; 374(15):1496-8. PubMed ID: 27074084
[No Abstract] [Full Text] [Related]
20. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J
Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]